 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
Volume 16, Number 17, Issue of September 1, 1996 pp. 5523-5535
Copyright ©1996 Society for NeuroscienceExpression of Normal and Mutant Huntingtin in the Developing Brain
Received Dec. 12, 1995; revised April 12, 1996; accepted May 22, 1996.
Pradeep G. Bhide, Michelle Day, Ellen Sapp, Cordula Schwarz, Ami Sheth, Johnny Kim, Anne B. Young, John Penney, Jeffrey Golden, Neil Aronin, and Marian DiFiglia Massachusetts General Hospital, Boston, Massachusetts 02114, Brigham and Women's Hospital, Boston, Massachusetts 02115, and University of Massachusetts Medical Center, Worcester, Massachusetts 01655
Huntington's disease (HD) is caused by a genetic mutation that results in a polyglutamine expansion in huntingtin. The time course of neuronal loss in the HD striatum and other affected brain regions before the onset of symptoms is unknown. To determine the potential influence of huntingtin on brain development, we examined its expression in the developing mouse and in human control and HD brain. By Western blot, huntingtin was detected throughout the adult mouse brain and at all stages of embryonic and postnatal brain development. The protein increased significantly between postnatal day 7 (P7) and P15, which marks a period of active neuronal differentiation and enhanced sensitivity to excitotoxic injury in the rodent striatum. Immunoreactivity was found in neurons throughout the brain and localized mostly to the somatodendritic cytoplasm and to axons in fiber bundles. Staining was variable in different groups of neurons and within the same cell population. In developing brain, huntingtin was limited primarily to neuronal perikarya. Increased immunoreactivity in large neurons followed the gradient of neurogenesis and appeared in the basal forebrain and brainstem by embryonic days 15-17, in regions of cortex by P0-P1, and in the striatum by P7. In human brain at midgestation (19-21 weeks), huntingtin was detected in all regions. The brain of a 10-week-old infant with the expanded HD allele expressed a higher molecular weight mutant form of huntingtin at levels comparable to those of the wild-type protein. Thus, mutant huntingtin is expressed before neuronal maturation is complete. Results suggest that huntingtin has an important constitutive role in neurons during brain development, that heterogeneity in neuronal expression of the protein is developmentally regulated, and that the intraneuronal distribution of huntingtin increases in parallel with neuronal maturation. The presence of mutant huntingtin in the immature HD brain raises the possibility that neurons may be affected during brain development and possibly in the postnatal period when vulnerability to excitotoxic injury is at its peak.
Key words: huntingtin; mutant huntingtin; Huntington's disease; striatum embryonic brain; postnatal brain
This article has been cited by other articles:
D. E. Ehrnhoefer, S. L. Butland, M. A. Pouladi, and M. R. Hayden
Mouse models of Huntington disease: variations on a theme
Dis. Model. Mech., March 1, 2009; 2(3-4): 123 - 129.
[Abstract] [Full Text] [PDF]
L.-S. Her and L. S. B. Goldstein
Enhanced Sensitivity of Striatal Neurons to Axonal Transport Defects Induced by Mutant Huntingtin
J. Neurosci., December 10, 2008; 28(50): 13662 - 13672.
[Abstract] [Full Text] [PDF]
R. C. Wolf, N. Vasic, C. Schonfeldt-Lecuona, G. B. Landwehrmeyer, and D. Ecker
Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI
Brain, November 1, 2007; 130(11): 2845 - 2857.
[Abstract] [Full Text] [PDF]
P. Nopoulos, V. A. Magnotta, A. Mikos, H. Paulson, N. C. Andreasen, and J. S. Paulsen
Morphology of the Cerebral Cortex in Preclinical Huntington's Disease
Am J Psychiatry, September 1, 2007; 164(9): 1428 - 1434.
[Abstract] [Full Text] [PDF]
A. N.T. Strehlow, J. Z. Li, and R. M. Myers
Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space
Hum. Mol. Genet., February 15, 2007; 16(4): 391 - 409.
[Abstract] [Full Text] [PDF]
Y. Takeshita, R. Fujinaga, C. Zhao, A. Yanai, and K. Shinoda
Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis
Hum. Mol. Genet., August 1, 2006; 15(15): 2298 - 2312.
[Abstract] [Full Text] [PDF]
C. M. Everett and N. W. Wood
Trinucleotide repeats and neurodegenerative disease
Brain, November 1, 2004; 127(11): 2385 - 2405.
[Abstract] [Full Text] [PDF]
L. B. Menalled, J. D. Sison, Y. Wu, M. Olivieri, X.-J. Li, H. Li, S. Zeitlin, and M.-F. Chesselet
Early Motor Dysfunction and Striosomal Distribution of Huntingtin Microaggregates in Huntington's Disease Knock-In Mice
J. Neurosci., September 15, 2002; 22(18): 8266 - 8276.
[Abstract] [Full Text] [PDF]
K. B. Kegel, A. R. Meloni, Y. Yi, Y. J. Kim, E. Doyle, B. G. Cuiffo, E. Sapp, Y. Wang, Z.-H. Qin, J. D. Chen, et al.
Huntingtin Is Present in the Nucleus, Interacts with the Transcriptional Corepressor C-terminal Binding Protein, and Represses Transcription
J. Biol. Chem., February 22, 2002; 277(9): 7466 - 7476.
[Abstract] [Full Text] [PDF]
A. Reiner, N. Del Mar, C. A. Meade, H. Yang, I. Dragatsis, S. Zeitlin, and D. Goldowitz
Neurons Lacking Huntingtin Differentially Colonize Brain and Survive in Chimeric Mice
J. Neurosci., October 1, 2001; 21(19): 7608 - 7619.
[Abstract] [Full Text] [PDF]
A. Petersen, K. E. Larsen, G. G. Behr, N. Romero, S. Przedborski, P. Brundin, and D. Sulzer
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
Hum. Mol. Genet., June 1, 2001; 10(12): 1243 - 1254.
[Abstract] [Full Text] [PDF]
L. M. Mende-Mueller, T. Toneff, S.-R. Hwang, M.-F. Chesselet, and V. Y. H. Hook
Tissue-Specific Proteolysis of Huntingtin (htt) in Human Brain: Evidence of Enhanced Levels of N- and C-Terminal htt Fragments in Huntington's Disease Striatum
J. Neurosci., March 15, 2001; 21(6): 1830 - 1837.
[Abstract] [Full Text] [PDF]
F. R. Fusco, Q. Chen, W. J. Lamoreaux, G. Figueredo-Cardenas, Y. Jiao, J. A. Coffman, D. J. Surmeier, M. G. Honig, L. R. Carlock, and A. Reiner
Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington's Disease
J. Neurosci., February 15, 1999; 19(4): 1189 - 1202.
[Abstract] [Full Text] [PDF]
M. Kim, H-S Lee, G. LaForet, C. McIntyre, E. J. Martin, P. Chang, T. W. Kim, M. Williams, P. H. Reddy, D. Tagle, et al.
Mutant Huntingtin Expression in Clonal Striatal Cells: Dissociation of Inclusion Formation and Neuronal Survival by Caspase Inhibition
J. Neurosci., February 1, 1999; 19(3): 964 - 973.
[Abstract] [Full Text] [PDF]
J.-H. J. Cha, C. M. Kosinski, J. A. Kerner, S. A. Alsdorf, L. Mangiarini, S. W. Davies, J. B. Penney, G. P. Bates, and A. B. Young
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
PNAS, May 26, 1998; 95(11): 6480 - 6485.
[Abstract] [Full Text] [PDF]
S.-H. Li, C.-A. Gutekunst, S. M. Hersch, and X.-J. Li
Interaction of Huntingtin-Associated Protein with Dynactin P150Glued
J. Neurosci., February 15, 1998; 18(4): 1261 - 1269.
[Abstract] [Full Text] [PDF]
M. DiFiglia, E. Sapp, K. O. Chase, S. W. Davies, G. P. Bates, J. P. Vonsattel, and N. Aronin
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
Science, September 26, 1997; 277(5334): 1990 - 1993.
[Abstract] [Full Text]
R. J. Ferrante, C.-A. Gutekunst, F. Persichetti, S. M. McNeil, N. W. Kowall, J. F. Gusella, M. E. MacDonald, M. F. Beal, and S. M. Hersch
Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum
J. Neurosci., May 1, 1997; 17(9): 3052 - 3063.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|